Childhood cancers trials in Japan

In Japan 48 Also abroad 2459

48 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in Japan
Where
Minato-ku, Tokyo
Age
4 years to 17 years
People
20
Run by
Bristol-Myers Squibb
See details and how to joinNCT07755826
Phase 1Taking people
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
Where
Fukuoka
Age
1 year to 24 years
People
61
Run by
Kyushu University
See details and how to joinNCT05608148
Phase 2Taking people
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Where
Chūōku, Fukuoka, Kobe
Age
1 year to 39 years
People
105 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05999994
Phase 2Taking people
Study to ONO-4538 in Patients With Rhabdoid Tumor
Where
Chiba, Chuo Ku, Fukuoka, Fukushima, Hiroshima, Kanazawa, Kobe, Kyoto, Miyagi, Nagoya, Niigata, Osaka, Sapporo, Tokyo
Age
1 year and over
People
23
Run by
Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT06622941
Phase 1/2Taking people
A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
Where
Chūō, Fukuoka, Kobe, Kyoto, Nagoya, Sapporo
Age
6 months and over
People
20
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07302347
No phaseTaking people
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Where
Multiple Locations
People
100
Run by
Bayer
See details and how to joinNCT04945330
No phaseTaking people
Special Drug Use-results Surveillance of Tafinlar/Mekinist
Where
Akita, Amagasaki, Bunkyo Ku, Chiba, Chuo Ku, Daisen, Fukuoka, Fukuyama, Funabashi, Habikino, Hiroshima, Iida, Izumisano, Kagoshima, Kashiwa, Kawagoe, Kobe, Kochi, Kurume, Kyoto, Matsumoto, Minato Ku, Mito, Morioka, Nagakute, Nagoya, Natori-shi, Ohtsu, Okayama, Osaka, Sagamihara, Saitama, Sapporo, Sendai, Setagaya-ku, Shibuya City, Shimotsuke, Shinjuku Ku, Shizuoka, Sunto Gun, Takatsuki, Toyohashi, Toyota, Wakayama, Yamagata, Yokohama, Yoshida-gun, Yufu
Age
6 years to 99 years
People
110
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06262919
Phase 1Taking people
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
Where
Chūō, Kashiwa, Niigata, Yokohama
Age
2 years and over
People
66
Run by
Chiome Bioscience Inc.
See details and how to joinNCT06636435
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Chuo Ku, Kashiwa, Nagoya, Osaka, Sapporo, Tōon, Yokohama, Yonago
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 3Taking people
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Where
Chūō, Fukuoka, Kyoto, Osaka, Sapporo, Tokyo
People
510 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00
No phaseTaking people
A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
Where
Tokyo
Age
Up to 18 years
People
8
Run by
Takeda
See details and how to joinNCT05481437
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Bunkyō City, Bunkyo-ku, Fukuoka, Fukushima, Hokkaido, Isehara-Shi, Kashiwa-shi, Miyagi, Nagasaki, Okayama, Osaka, Yoshida-gun
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
No phaseTaking people
Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer
Where
Tokyo
People
500
Run by
Takeda
See details and how to joinNCT05100069
No phaseTaking people
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
Where
Nagoya
People
1,050 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT03141021
No phaseTaking people
A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy
Where
Tokyo
People
60
Run by
Eisai Co., Ltd.
See details and how to joinNCT06793709
No phaseTaking people
Primary Tumor Research and Outcomes Network
Where
Kanazawa
People
1,350 worldwide
Run by
AO Innovation Translation Center
See details and how to joinNCT02790983
No phaseTaking people
Asian Gynecological Brachytherapy Registry in Cervical Cancer
Where
Maebashi, Tokyo
People
1,000 worldwide
Run by
Tata Memorial Hospital
See details and how to joinNCT07196033
No phaseTaking people
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
Where
Kumamoto, Toyokawa
People
50 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06357754
No phaseTaking people
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Where
Tokyo
People
2,000 worldwide
Run by
Stanford University
See details and how to joinNCT02848274
No phaseTaking people
Evaluation Using FAPI-PET Targeting Cancer-associated Fibroblasts
Where
Suita
People
200
Run by
Tadashi Watabe
See details and how to joinNCT05442151
No phaseEnrolling by invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
Where
Tokyo
Age
1 day and over
People
500 worldwide
Run by
Prof. Valérie Mc Lin
See details and how to joinNCT06041906
No phaseTaking people
International Chronic Myeloid Leukemia Pediatric Study
Where
Tokyo
Age
Up to 18 years
People
750 worldwide
Run by
Poitiers University Hospital
See details and how to joinNCT01281735
Phase 2Taking people
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Where
Chuo-ku, Fukuoka, Kashiwa, Kyoto, Sapporo, Sendai
Age
12 years and over
People
32
Run by
National Cancer Center, Japan
See details and how to joinNCT06159478